uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted June 16, 2004

Ads for Various Diet Pills and Topical Gels Don’t Cut the Fat, Says the FTC

On June 16, 2004, The Federal Trade Commission (FTC)charged a Utah-based company, five related corporations, and three individuals operating as a common enterprise with making numerous false and unsubstantiated claims for weight-loss and fat-loss gels and supplements. The complaint focuses on six of the respondents’ heavily promoted products: Dermalin, Cutting Gel, and Tummy Flattening Gel (topical fat-loss gels with the same active ingredient); Leptoprin and Anorex (identical weight-loss supplements for “significantly overweight” people which contained ECA [ephedrine, caffeine and aspirin], an additional patented ingredient and calcium); and PediaLean (a glucomannan weight-loss supplement for children). In an administrative complaint announced today, the FTC alleges that the respondents violated the FTC Act by making unsubstantiated fat and weight loss claims, false claims that clinical testing proves certain efficacy claims, and false claims that Daniel B. Mowrey, Ph.D, is a medical doctor.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at